Related references
Note: Only part of the references are listed.Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
Kirati Kengkla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors
Ga Eun Park et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Active efflux pump adeB is involved in multidrug resistance of Acinetobacter baumannii induced by antibacterial agents
Tingting Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials
Emmanuel Weiss et al.
CRITICAL CARE (2017)
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy
Ji-Yong Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients
Constantinos Tsioutis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
Wentao Ni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
Won-Young Kim et al.
PLOS ONE (2016)
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study
Aristine Cheng et al.
CRITICAL CARE MEDICINE (2015)
In Vitro Potential of Lycosin-I as an Alternative Antimicrobial Drug for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
Ling Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
Yu-Chung Chuang et al.
BMC INFECTIOUS DISEASES (2014)
Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
Gloria Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
Y. -T. Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
Sujata M. Bhavnani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Is Tigecycline a Good Choice in the Treatment of Multidrug-Resistant Acinetobacter baumannii Pneumonia?
M. S. Tasbakan et al.
JOURNAL OF CHEMOTHERAPY (2011)
The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
Jung-Jr Ye et al.
JOURNAL OF INFECTION (2011)
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Efthimia Tasina et al.
LANCET INFECTIOUS DISEASES (2011)
Late Onset Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter spp.: Experience with Tigecycline
D. Curcio et al.
JOURNAL OF CHEMOTHERAPY (2009)
Tigecycline pharmacokinetic/pharmacodynamic update
Alasdair P. MacGowan
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
Jason J. Schafer et al.
PHARMACOTHERAPY (2007)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Share Paper
